ArticleJAMA ophthalmology2022
Detecting Anomalies in Retinal Diseases Using Generative, Discriminative, and Self-supervised Deep Learning.
Article in JAMA ophthalmology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
17 citing papers in PubMed.
- Systemic metabolic dysfunction is associated with local treatment failure: the role of visceral adiposity index in anti-VEGF resistance in diabetic macular edema.Frontiers in endocrinology · 2026Article
- Beyond convolutions and supervised learning with transformers and representation learning for retinal image analysis.Progress in retinal and eye research · 2026Review
- A Self-Supervised Equivariant Refinement Classification Network for Diabetic Retinopathy Classification.Journal of imaging informatics in medicine · 2025Article
- Practical Applications of Artificial Intelligence Diagnostic Systems in Fundus Retinal Disease Screening.International journal of general medicine · 2025Article
- Anomaly Detection and Biomarkers Localization in Retinal Images.Journal of clinical medicine · 2024Article
- Clinical evaluation of deep learning systems for assisting in the diagnosis of the epiretinal membrane grade in general ophthalmologists.Eye (London, England) · 2024Article
- AI-Human Hybrid Workflow Enhances Teleophthalmology for the Detection of Diabetic Retinopathy.Ophthalmology science · 2023Article
- Uncertainty-inspired open set learning for retinal anomaly identification.Nature communications · 2023Article
- Article
- Accuracy of Artificial Intelligence in Estimating Best-Corrected Visual Acuity From Fundus Photographs in Eyes With Diabetic Macular Edema.JAMA ophthalmology · 2023Article
- SynthEye: Investigating the Impact of Synthetic Data on Artificial Intelligence-assisted Gene Diagnosis of Inherited Retinal Disease.Ophthalmology science · 2023Article
- A Multi-Modal AI-Driven Cohort Selection Tool to Predict Suboptimal Non-Responders to Aflibercept Loading-Phase for Neovascular Age-Related Macular Degeneration: PRECISE Study Report 1.Journal of clinical medicine · 2023Article
- Computer vision - ECCV ... : ... European Conference on Computer Vision : proceedings. European Conference on Computer Vision · 2022Article
- Does everyone understand the terminology 'borrowed' from computer sciences creeping into medical sciences?Annals of translational medicine · 2022Article
- Artificial intelligence promotes the diagnosis and screening of diabetic retinopathy.Frontiers in endocrinology · 2022Review
- Discriminative, generative artificial intelligence, and foundation models in retina imaging.Taiwan journal of ophthalmologyReview
- Artificial intelligence and deep learning in ophthalmology: Current status and future perspectives.Advances in ophthalmology practice and researchReview
Corrections and comments
- Commented on by
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
importanceAnomaly detectors could be pursued for retinal diagnoses based on artificial intelligence systems that may not have access to training examples for all retinal diseases in all phenotypic presentations. Possible applications could include screening of population for any retinal disease rather than a specific disease such as diabetic retinopathy, detection of novel retinal diseases or novel presentations of common retinal diseases, and detection of rare diseases with little or no data available for training.
objectiveTo study the application of anomaly detection to retinal diseases. DESIGN, SETTING, AND
participantsHigh-resolution retinal images from the publicly available EyePACS data set with fundus images with a corresponding label ranging from 0 to 4 for representing different severities of diabetic retinopathy. Sixteen variants of anomaly detectors were designed. For evaluation, a surrogate problem was constructed, using diabetic retinopathy images, in which only retinas with nonreferable diabetic retinopathy, ie, no diabetic macular edema, and no diabetic retinopathy or mild to moderate nonproliferative diabetic retinopathy were used for training an artificial intelligence system, but both nonreferable and referable diabetic retinopathy (including diabetic macular edema or proliferative diabetic retinopathy) were used to test the system for detecting retinal disease. MAIN OUTCOMES AND MEASURES: Anomaly detectors were evaluated by commonly accepted performance metrics, including area under the receiver operating characteristic curve, F1 score, and accuracy.
resultsA total of 88 692 high-resolution retinal images of 44 346 individuals with varying severity of diabetic retinopathy were analyzed. The best performing across all anomaly detectors had an area under the receiver operating characteristic of 0.808 (95% CI, 0.789-0.827) and was obtained using an embedding method that involved a self-supervised network. CONCLUSIONS AND RELEVANCE: This study suggests when abnormal (diseased) data, ie, referable diabetic retinopathy in this study, were not available for training of retinal diagnostic systems wherein only nonreferable diabetic retinopathy was used for training, anomaly detection techniques were useful in identifying images with and without referable diabetic retinopathy. This suggests that anomaly detectors may be used to detect retinal diseases in more generalized settings and potentially could play a role in screening of populations for retinal diseases or identifying novel diseases and phenotyping or detecting unusual presentations of common retinal diseases.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.